Israel's Device Community: Opportunities and Challenges Ahead

This article is excerpted from "Israel's Device Community: Finding New Models as Medtech Matures," In Vivo, October 2008. (Article number 2008800161.)

by David Cassak

Editor’s Note: The following article is excerpted from "Israel’s Device Community: Finding New Models as Medtech Matures," published in the October 2008 issue of IN VIVO.

More from Archive

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By 

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.